Methods and Effect of Management of Patients with Convergence Spasm and Aquired Pseudomyopia.
10.3341/jkos.2015.56.10.1630
- Author:
Il Joo KWON
1
;
Suk Gyu HA
;
Seung Hyun KIM
Author Information
1. Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea. ansaneye@hanmail.net
- Publication Type:Original Article
- Keywords:
Accommodative spasm;
Convergence spasm;
Near reflex spasm;
Pseudomyopia
- MeSH:
Academic Medical Centers;
Esotropia;
Humans;
Korea;
Medical Records;
Methods*;
Miosis;
Mydriatics;
Prognosis;
Pupil;
Recurrence;
Refractive Errors;
Spasm*;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2015;56(10):1630-1634
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate changes in the degree of pseudomyopia and prognosis in patients with convergence spasm and acquired pseudomyopia. METHODS: The medical records of patients with convergence spasm and acquired pseudomyopia at the Korea University Medical Center from 2011 to 2014 were identified. We reviewed the patients' gender, age, onset time, visual acuity, refractive error, angle of strabismic deviation and the selected management (cycloplegics, patching, cycloplegics + patching, prism glasses). RESULTS: At the first medical examination, the mean age was 20.08 years. The mean spherical equivalent was -3.75 diopter (D) in the right eye and -4.03 D in the left eye based on manifest refraction and -2.59 D in right eye and -2.85 D in left eye using cycloplegic refraction. Eleven of 12 patients had esodeviation with a mean esodeviation of 10.42 D. The pupil size was 3.63 mm in the right eye and 3.63 mm in the left eye. No patient experienced severe miosis (pupil size <2 mm). Observation (5), patching (3), cycloplegics (2), patching + cycloplegics (1) and prism (1) management were performed in 12 patients. Outcomes included completely cured (3), improvement (7) and no change or recurrence (2). CONCLUSIONS: Active management is necessary for patients with convergence spasm and acquired pseudomyopia.